72934-4147 : Minoxidil 7% / Niacinamide 4% Topical Solution


NDC: 72934-4147
Labeler: Sincerus Florida, LLC
Product Type: Human Prescription Drug
Drug Name: Minoxidil 7% / Niacinamide 4% S
Dosage Form: Topical Solution
Rev. Date: 


NDC Package Codes:

  • 72934-4147-8: 60 G IN 1 BOTTLE, PUMP (72934‑4147‑8)

Active Ingredients:

  • Minoxidil
  • Niacinamide

Dosage Strength:

  • 7 g/100g
  • 4 g/100g

Pharmaceutical Classes:

  • Arteriolar Vasodilation [PE]
  • Arteriolar Vasodilator [EPC]

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 72934-4147 QR Code

< Prev: 72934-4146Next: 72934-4149 >

Related Discussions:

NICOMIDE (NIACINAMIDE)
prescribed by Dermatolagist for treatment of facial skin inflamation such as Rosachia or acne. From SIRIUS. 1 Tablet by ...
Tabs containing: biotin, niacinamide, paba, calcium, folic acid and selenium
I'm searching for tablets containing: Biotin 10mg + Niacinamide 30mg + Para amino benzoic acid 100mg + Zinc Oxide 25... 1 reply
Warning! Interaction Between Propranolol + Minoxidil (Rogaine)
Hi, I was taking propranolol to help with anxiety. Dosage was dependent on how bad anxiety was on any given day. I was s... 1 reply
Niacinamide
Niapads (niacinamide acne pads) is a one simple step topical treatment that helps exfoliate, open clogged skin pores and...
which capsules include Niacinamide in large number
which capules includes large number of vitamin B,B2,B3,B6,B12,folic acid,biotin and niacinamide...
2 Minoxidil Aminexil Topical Solution
i want to know if the solution is safe to use for hair fall treatment and what precautions to be taken while using it....




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.